Medicines and Related Substances Act, 1965
R 385
deserving of leniency
when used with respect to a firm contemplated in section 50, or a person contemplated in section 73A, means that the firm or person has provided information to the Competition Commission, or otherwise co-operated with the Commission's investigation of an alleged prohibited practice in terms of section 4 (1)(b) to the satisfaction of the Commission;
[Definition inserted by section 1(c) of Notice No. 875, GG 32533, dated 28 August 2009]
